The Value of Health and Longevity

We develop a framework for valuing improvements in health and apply it to past and prospective reductions in mortality in the United States. We calculate social values of (i) increased longevity over the twentieth century, (ii) progress against various diseases after 1970, and (iii) potential future progress against major diseases. Cumulative gains in life expectancy after 1900 were worth over $1.2 million to the representative American in 2000, whereas post‐1970 gains added about $3.2 trillion per year to national wealth, equal to about half of GDP. Potential gains from future health improvements are also large; for example, a 1 percent reduction in cancer mortality would be worth $500 billion.

[1]  Michael J. Moore,et al.  The Quantity-Adjusted Value of Life , 1988 .

[2]  D. Cutler,et al.  Measuring the Health of the U.S. Population , 1997 .

[3]  V. Fuchs.  Health care and the United States economic system. An essay in abnormal physiology. , 1972, The Milbank Memorial Fund quarterly.

[4]  Finis Welch,et al.  Efficient Labor Contracts with Employment Risk , 1986 .

[5]  W. Arthur.  The economics of risks to life. , 1979, The American economic review.

[6]  L. Hansen,et al.  Stochastic Consumption, Risk Aversion, and the Temporal Behavior of Asset Returns , 1983, Journal of Political Economy.

[7]  Thomas F. Crossley,et al.  The Life Cycle Model of Consumption and Saving , 2000 .

[8]  F. Lichtenberg.  The Allocation of Publicly-Funded Biomedical Research , 1997 .

[9]  D. Usher.  An Imputation to the Measure of Economic Growth for Changes in Life Expectancy , 1973 .

[10]  C. I. Jones,et al.  The Value of Life and the Rise in Health Spending , 2004 .

[11]  Robert E. Hall.  Intertemporal Substitution in Consumption , 1988 .

[12]  J. Banks,et al.  Is There a Retirement-Savings Puzzle? , 1995 .

[13]  J. Lynn,et al.  Medicare beneficiaries' costs of care in the last year of life. , 2001, Health affairs.

[14]  Robert Fabian,et al.  Valuing health for policy : an economic approach , 1995 .

[15]  D. Duff.  The future of health care in Canada. , 2002, Axone.

[16]  Matthew T. Jones,et al.  Saving, Investment, and Gold: A Reassessment of Historical Current Account Data , 1997 .

[17]  Jesús Fernández-Villaverde,et al.  Consumption over the Life Cycle: Some Facts from Consumer Expenditure Survey Data , 2002 .

[18]  Kevin M. Murphy,et al.  The Economic Value of Medical Research , 2000 .

[19]  P. Johansson.  On the value of changes in life expectancy. , 1996, Journal of health economics.

[20]  Casey B. Mulligan,et al.  The Endogenous Determination of Time Preference , 1997 .

[21]  D. Cutler.  Technology, Health Costs, and the NIH , 1995 .

[22]  W. Viscusi,et al.  The value of risks to life and health , 1993 .

[23]  M. Ezzati.  Indoor air pollution and health in developing countries , 2005, The Lancet.

[24]  Kevin M. Murphy,et al.  Measuring the Gains from Medical Research: An Economic Approach , 2003 .

[25]  James J. Heckman,et al.  Micro data and general equilibrium models , 1999 .

[26]  D. Meltzer.  Can Medical Cost-Effectiveness Analysis Identify the Value of Research? , 2003 .

[27]  Zvi Griliches,et al.  R and D and Productivity at the Industry Level: Is There Still a Relationship? , 1982 .

[28]  Reshmi M. Siddique,et al.  Valuing Health for Policy: An Economic Approach , 1996 .

[29]  Richard H. Thaler,et al.  The Value of Saving a Life: Evidence from the Labor Market , 1976 .

[30]  R. Topel,et al.  Black-White Differences in the Economic Value of Improving Health , 2005 .

[31]  Miles S. Kimball,et al.  Preference Parameters and Behavioral Heterogeneity: An Experimental Approach in the Health and Retirement Survey , 1995 .

[32]  J. Eichel,et al.  Evolution And Human Nature , 2016 .

[33]  G. Borjas,et al.  Time-Series Evidence on the , 1994 .

[34]  W. Nordhaus,et al.  The Health of Nations: The Contribution of Improved Health to Living Standards , 2002 .

[35]  F. Lichtenberg,et al.  Are the benefits of newer drugs worth their cost? Evidence from the 1996 MEPS. , 2001, Health affairs.

[36]  Joseph E. Aldy,et al.  The Value of a Statistical Life: A Critical Review of Market Estimates Throughout the World , 2003 .

[37]  Majid Ezzati,et al.  HOW ENVIRONMENTAL HEALTH RISKS CHANGE WITH DEVELOPMENT: The Epidemiologic and Environmental Risk Transitions Revisited , 2005 .

[38]  John Y. Campbell,et al.  Consumption, Income, and Interest Rates: Reinterpreting the Time Series Evidence , 1989, NBER Macroeconomics Annual.